17

January 17, 2015

Natural product-based antimetastatic therapy: Rhamnetin, an O-methylated flavonol isolated from cloves, suppresses the expression Lymphoid enhancer-binding factor-1 (LEF1) via up regulation of its target gene, 17/January/20145, 22.00

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based antimetastatic therapy: Rhamnetin, an O-methylated flavonol isolated from cloves, suppresses the expression Lymphoid enhancer-binding factor-1 […]
January 17, 2015

MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 21.46

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, […]
January 17, 2015

Mechanistic insight into interleukin-mediated tumorigenesis: Interleukin-17 (IL-17) decreases the stability and activity of p73α and promotes tumorigenesis via down regulation of its target gene, 17/January/2015, 21.22

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Mechanistic insight into interleukin-mediated tumorigenesis: Interleukin-17 (IL-17) decreases the stability and activity of p73α and promotes tumorigenesis […]
January 17, 2015

MiRNA-based molecular therapy for Acute Myeloid Leukeima (AML): NRF2 suppresses the expression of 5-Lipoxygenase (5-LO) and inhibits cancer stem cell proliferation via up regulation of its target gene, 17/January/2015, 18.02

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based molecular therapy for  Acute Myeloid Leukeima (AML): NRF2 suppresses the expression of 5-Lipoxygenase (5-LO) and inhibits […]